Sarepta Therapeutics, Inc. (SRPT) Social Stream
SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SRPT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 16 | $160 | $90 | $127.25 | $128.86 | -1.25% |
| 2021-12-26 | 16 | $160 | $90 | $127.076 | $128.86 | -1.38% |
| 2022-01-05 | 16 | $160 | $90 | $126.538 | $128.86 | -1.8% |
| 2022-01-11 | 13 | $160 | $90 | $128.083 | $128.86 | -0.6% |
| 2022-01-19 | 14 | $160 | $90 | $128.083 | $128.86 | -0.6% |
| 2022-01-26 | 14 | $160 | $92 | $126.833 | $128.86 | -1.57% |
| 2022-02-09 | 14 | $160 | $71 | $125.083 | $128.86 | -2.93% |
| 2022-03-04 | 13 | $150 | $71 | $121.909 | $128.86 | -5.39% |
| 2022-03-07 | 13 | $150 | $80 | $122.727 | $128.86 | -4.76% |
| 2022-03-16 | 13 | $150 | $80 | $123 | $128.86 | -4.55% |
| 2022-04-04 | 13 | $150 | $80 | $124.3 | $128.86 | -3.54% |
| 2022-04-12 | 13 | $150 | $77 | $124 | $128.86 | -3.77% |
| 2022-04-20 | 13 | $150 | $77 | $124.2 | $128.86 | -3.62% |
| 2022-05-09 | 13 | $150 | $77 | $124.1 | $128.86 | -3.69% |
| 2022-05-13 | 13 | $150 | $77 | $124.6 | $128.86 | -3.31% |
| 2022-05-18 | 13 | $150 | $74 | $124.3 | $128.86 | -3.54% |
| 2022-05-24 | 14 | $155 | $74 | $127.09 | $128.86 | -1.37% |
| 2022-06-22 | 13 | $155 | $74 | $127.09 | $128.86 | -1.37% |
| 2022-07-25 | 13 | $155 | $80 | $126.272 | $128.86 | -2.01% |
| 2022-07-29 | 13 | $162 | $80 | $127.363 | $128.86 | -1.16% |
| 2022-08-03 | 13 | $162 | $80 | $127.583 | $128.86 | -0.99% |
| 2022-08-04 | 13 | $162 | $100 | $132.076 | $128.86 | 2.5% |
| 2022-08-09 | 13 | $182 | $100 | $133.769 | $128.86 | 3.81% |
| 2022-08-13 | 13 | $182 | $100 | $134.923 | $128.86 | 4.71% |
| 2022-09-06 | 13 | $182 | $100 | $136.461 | $128.86 | 5.9% |
| 2022-09-07 | 13 | $182 | $100 | $137.461 | $128.86 | 6.67% |
| 2022-09-14 | 13 | $182 | $114 | $140.153 | $128.86 | 8.76% |
| 2022-10-03 | 12 | $182 | $114 | $140.153 | $128.86 | 8.76% |
| 2022-10-12 | 12 | $182 | $114 | $141.916 | $128.86 | 10.13% |
| 2022-10-20 | 12 | $182 | $114 | $143.5 | $128.86 | 11.36% |
| 2022-10-21 | 12 | $182 | $114 | $144 | $128.86 | 11.75% |
| 2022-11-25 | 12 | $190 | $114 | $146.153 | $128.86 | 13.42% |
| 2022-12-02 | 12 | $190 | $114 | $146.846 | $128.86 | 13.96% |
| 2022-12-19 | 13 | $190 | $114 | $147.642 | $128.86 | 14.58% |
| 2022-12-22 | 14 | $190 | $114 | $148.466 | $128.86 | 15.21% |
| 2022-12-29 | 14 | $190 | $114 | $150.066 | $128.86 | 16.46% |
| 2023-01-04 | 15 | $190 | $114 | $151.533 | $128.86 | 17.6% |
| 2023-01-10 | 15 | $190 | $114 | $151.666 | $128.86 | 17.7% |
| 2023-01-16 | 15 | $190 | $122 | $152.4 | $128.86 | 18.27% |
| 2023-02-27 | 15 | $190 | $122 | $153.4 | $128.86 | 19.04% |
| 2023-03-01 | 16 | $190 | $122 | $154.933 | $128.86 | 20.23% |
| 2023-03-02 | 16 | $226 | $122 | $169 | $128.86 | 31.15% |
| 2023-03-09 | 16 | $226 | $122 | $170.533 | $128.86 | 32.34% |
| 2023-03-17 | 16 | $226 | $122 | $171.666 | $128.86 | 33.22% |
| 2023-03-21 | 16 | $226 | $122 | $171.333 | $128.86 | 32.96% |
| 2023-03-22 | 16 | $226 | $122 | $174.666 | $128.86 | 35.55% |
| 2023-04-05 | 18 | $226 | $122 | $174.058 | $128.86 | 35.08% |
| 2023-04-24 | 18 | $226 | $122 | $173.823 | $128.86 | 34.89% |
| 2023-05-03 | 19 | $226 | $122 | $174.444 | $128.86 | 35.37% |
| 2023-05-04 | 19 | $206 | $122 | $170.222 | $128.86 | 32.1% |
| 2023-05-10 | 19 | $206 | $122 | $171.5 | $128.86 | 33.09% |
| 2023-05-15 | 19 | $206 | $122 | $173 | $128.86 | 34.25% |
| 2023-05-24 | 19 | $218 | $122 | $177 | $128.86 | 37.36% |
| 2023-05-25 | 19 | $218 | $122 | $176.722 | $128.86 | 37.14% |
The Trend in the Analyst Price Target
Over the past 25 months, SRPT's average price target has gone up $42.37.
Over the past 48 weeks, SRPT's average upside potential has been 27.31%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-09 | 13 | 182 | 100 | 133.769 | 109.10 | 22.61% |
| 2022-08-13 | 13 | 182 | 100 | 134.923 | 109.00 | 23.78% |
| 2022-11-03 | 12 | 190 | 114 | 146.153 | 105.01 | 39.18% |
| 2023-01-16 | 15 | 190 | 122 | 152.400 | 126.70 | 20.28% |
| 2023-01-31 | 15 | 190 | 122 | 153.400 | 124.97 | 22.75% |
SRPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.32 | 15 | 2 | 2 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
Over the past 36 months, SRPT's average broker recommendation rating worsened by 0.15.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SRPT has a higher average analyst price target than 5503.88% of Pharmaceutical Products stocks.
- SAREPTA THERAPEUTICS INC's number of analysts covering the stock is higher than 5371.37% of Pharmaceutical Products stocks.
- In terms of how SAREPTA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 862.82% of that group.
- SRPT has a lower variance in analysts' estimates than -3852.62% of stocks in the large market cap category.
In the Pharmaceutical Products industry, REGN, BMY, and LEGN are the three stocks most similar to SAREPTA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding SRPT using the data that counts. Try POWR Ratings for free.